EUCTR2014-003466-25-DK进行中（未招募）1 期
Randomized, double-blind, prospective, placebo-controlled trial of the effect of intravenous lidocaine infusion for postoperative pain management and bowel function in robot assisted laparoscopic colon surgery.
Anders Gadegaard Jensen,Anesthesia and Intensive Care Unit, Odense University Hospital0 个研究点开始时间: 2014年10月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients undergoing robotic assisted laparoscopic colon rectal cancer surgery and giving their informed consent to participate in the trial. Age = 18years of age. Danish-speaking patient.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Known hypersensitivity to the drug or local anesthetics of the amide type
- •Hepatic or renal impairment (ALT, AST, Bili> 2.5 x upper limit and CrCl <60ml / min)
- •Durable consumption of opioids and NSAIDs
- •Pregnancy or women of childbearing age without adequate contraception, breastfeeding women.Pregnancy test must be negative.
- •Treatment with beta blockers
- •Patients with known porphyria
研究者
相似试验
招募中
4 期
Prospective, randomized, double-blind, placebo-controlled, multicenter clinical investigation to determine the clinical performance and safety of Luvos® Healing Earth in patients with histamine-mediated recurrent digestive symptoms.T78.1T62K58K59Other adverse food reactions, not elsewhere classifiedToxic effect of other noxious substances eaten as foodOther functional intestinal disordersIrritable bowel syndromeDRKS00027333Heilerde-Gesellschaft Luvos Just GmbH % Co. KG114
进行中（未招募）
不适用
Dose finding study for a Botulinum toxin type A injection to treat habitual snoringEUCTR2011-001779-38-DEMerz Pharmaceuticals GmbH48
进行中（未招募）
1 期
Cineole in acute non-purulent rhinosinusitisEUCTR2016-002743-41-DEEngelhard Arzneimittel GmbH & Co. KG250
进行中（未招募）
不适用
Clinical study to investigate the efficacy and safety of NT 201 compared to placebo in the treatment of chronic troublesome drooling associated with neurological disorders and/or intellectual disabilityChronic troublesome sialorrhea associated with neurological disorders (e.g. cerebral palsy, traumatic brain injury) and/or intellectual disability in children and adolescentsMedDRA version: 18.0Level: PTClassification code 10039424Term: Salivary hypersecretionSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2013-004532-30-Outside-EU/EEAMerz Pharmaceuticals GmbH249
进行中（未招募）
1 期
Clinical study to investigate the efficacy and safety of NT 201 compared to placebo in the treatment of chronic troublesome drooling associated with neurological disorders and/or intellectual disabilityEUCTR2013-004532-30-HUMerz Pharmaceuticals GmbH249